News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investor's Business Daily100d agoneutral
AMD Stock Rebounds With Chips Ahead Of Q2 Report; SpaceX Earnings, Lockup Expiration Loom LargeInvestor's Business Daily107d agobullish
Eli Lilly Stock In A Buy Zone, Set To Ride The Peptide WaveThe Wall Street Journal107d agoneutral
Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss AdsThe Wall Street Journal107d agoneutral
Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss AdsBarrons.com108d agoneutral
Lilly Stock Is Rising on Plan to Seek Approval for Newest Weight-Loss Drug in 2027Simply Wall St.108d agobearish
How Novo Nordisk’s GLP-1 Advertising Lawsuit Against Eli Lilly (LLY) Has Changed Its Investment StoryBioPharma Dive108d agoneutral
Lilly, with new data, to seek FDA approval of obesity drug retatrutideThe Wall Street Journal108d agoneutral
Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss DataThe Wall Street Journal108d agoneutral
Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss DataSimply Wall St.110d agobearish
Is Eli Lilly (LLY) Undervalued After Novo Nordisk’s GLP 1 Advertising Lawsuit?